L. Vidot

Exploratory analysis of the effect of FTD/TPI in mCRC patients treated in RECOURSE by different prognostic factors: impact on ECOG PS

Introduction In the Phase III RECOURSE study, patients with metastatic colorectal cancer (mCRC) refractory to standard therapies demonstrated significantly extended overall survival and ...

Eric Van Cutsem , MD, PhD;

Alberto F. Sobrero , MD;

A. Ohtsu ;

Josep Tabernero , MD, PhD;

G. Argiles ;

R. Mayer ;

L. Vidot ;

S. Vera Moreno ;

07/01/2019

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

L. Vidot

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products